117 results for «100»

Filter By

117 results

Case report: Renal denervation using ultrasound energy (uRDN)

23 Oct 2024

In this case report, we examine an advanced technique for renal denervation (RDN)—ultrasound energy—employed to manage severe hypertension in patients with complex medical histories.

Joachim Weil

Author

Joachim Weil
Case report: Renal denervation using ultrasound energy (uRDN)

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device

16 May 2024

Coronary obstruction is a major concern in patients undergoing TAVI for degenerated bioprostheses (valve-in-valve [ViV]) and is associated with a 30-day mortality rate of around 50%.1 While several transcatheter techniques to lacerate bioprosthetic valve leaflets prior to TAVI placement (such as BASILICA) have been described, they are...

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device

Hypertension management in 2022: Latest data on renal denervation - EuroPCR 2022

17 May 2022

On the occasion of World Hypertension Day, Felix Mahfoud speaks about the value of renal denervation, including the latest data and what we can learn about renal denervation at EuroPCR 2022.

Author

Felix Mahfoud
Hypertension management in 2022: Latest data on renal denervation

COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)

18 Feb 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the Sputnik V vaccine

Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent

21 Jul 2022

Robocath demonstrates feasibility of robotic carotid stenting in ‘CARE’ clinical trial conducted at Rennes University Hospital

19 Oct 2023

2024 ESC Guidelines: Peripheral arterial and aortic diseases - Focus on Peripheral Arterial Diseases

09 Sep 2024

The 2024 ESC Guidelines for aortic diseases, merged with peripheral arterial disease guidelines, update prior guidance and emphasize atherosclerotic conditions. In this article, Antoine Sauguet summarizes the content related to peripheral arterial diseases.

Dr. Antoine Sauguet

Author

Antoine Sauguet
2024 ESC Guidelines: Peripheral arterial and aortic diseases - Focus on Peripheral Arterial Diseases

EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions

16 May 2024

EuroPCR 2021 - Unprecedented global outreach and online interactivity during an innovative livestreamed edition

25 May 2021

Paris, France. 21 May 2021.  Since 1989, EuroPCR has constantly pioneered innovative educational tools and formats to help the interventional cardiovascular community effectively share their knowledge, skills and practice. Rising up to the challenge of the pandemic, the 31st annual edition was fundamentally rethought, reshaped and...

EuroPCR 2021

EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

17 May 2023

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

01 Sep 2022

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Daniele Giacoppo

Author

Daniele Giacoppo
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

COVID-19: safety and efficacy of the mRNA-1273 SARSCoV-2 vaccine (Moderna) against SARS-CoV-2

22 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the Moderna vaccine

One-year results from the FUTURE-II trial

18 May 2021

A decade already passed from the first use of bioresorbable vascular scaffold in percutaneous coronary interventions. The first studies - by using surrogate endpoints - showed some superiority of BRS vs. metallic drug-eluting stent in terms of the so-called vascular restoration therapy with recovery of vasomotion...

One-year results from the FUTURE-II trial

Elixir Medical To Announce Late-Breaking Clinical Data at EuroPCR 2023 Session Featuring World’s First Transforming Coronary Artery Implant Designed to Restore Vessel Physiology and Function

09 May 2023

BIOTRONIK announces its latest innovation: Oscar multifunctional peripheral catheter

14 Feb 2023

ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock

27 Aug 2023

Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris

Author

Leonidas Koliastasis
ECLS-SHOCK

FIRE1 raises $25M to revolutionize heart failure home monitoring

15 Mar 2023

New data highlight promising angiographic and safety profile of BIOTRONIK’s third generation resorbable magnesium scaffold

16 Mar 2023

Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism: primary outcomes from the PEERLESS randomized controlled trial

30 Oct 2024

Elad Asher provides his take on the PEERLESS trial presented by Wissam A. Jaber at TCT 2024 in Washington.

Elad Asher

Author

Elad Asher
Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism
Didn’t find what you were looking for?